Heink, Sylvia
Yogev, Nir
Garbers, Christoph http://orcid.org/0000-0003-4939-6950
Herwerth, Marina
Aly, Lilian http://orcid.org/0000-0002-7051-124X
Gasperi, Christiane
Husterer, Veronika
Croxford, Andrew L
Möller-Hackbarth, Katja
Bartsch, Harald S
Sotlar, Karl
Krebs, Stefan
Regen, Tommy
Blum, Helmut
Hemmer, Bernhard
Misgeld, Thomas
Wunderlich, Thomas F
Hidalgo, Juan
Oukka, Mohamed
Rose-John, Stefan
Schmidt-Supprian, Marc
Waisman, Ari http://orcid.org/0000-0003-4304-8234
Korn, Thomas
Article History
Received: 9 May 2016
Accepted: 4 November 2016
First Online: 28 November 2016
Change Date: 23 January 2017
Change Type: Corrigendum
Change Details: In the version of this article initially published, the label for third bar from the left in Figure 4f ('Anti-IL-6α') was incorrect; the correct label is 'Anti-IL-6Rα'. Also, in the legend for Figure 4f, the description of the treatment conditions for middle four bars ('medium alone, or LPS and anti-IL-6 (MR16-1 or polyclonal antibody), anti-IL-6R (mAb#8)') was incorrect; the correct description is 'LPS alone (Medium), or LPS and anti-IL-6Rα (MR16-1), anti-IL-6 (polyclonal antibody or mAb#8)'. The error has been corrected for the print, PDF and HTML versions of this article.
Competing interests
: The authors declare no competing financial interests.